This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Pediatrics, Other  • Evidence-Based Medicine  • Review  • Prognosis/ Outcomes  • Review Articles  • Drug Therapy  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic

A Systematic Review and Meta-analysis

Lisa Ross DeCamp, MD, MSPH; Julie S. Byerley, MD, MPH; Nipa Doshi, BSPH; Michael J. Steiner, MD

Arch Pediatr Adolesc Med. 2008;162(9):858-865.

Objective  To perform a systematic review and meta-analysis to determine whether taking antiemetic drugs reduces vomiting and decreases the need for further intervention in children with gastroenteritis without causing significant adverse effects.

Data Sources  Computerized databases, reference lists, and expert recommendations.

Study Selection  Prospective controlled trials evaluating medication use in children with vomiting from gastroenteritis.

Intervention  Antiemetic drug therapy.

Main Outcome Measures  Emesis cessation, use of intravenous fluid for rehydration, hospital admission, return to care, and medication adverse effects.

Results  The 11 articles that met the inclusion criteria evaluated various antiemetic agents: ondansetron (n = 6), domperidone (n = 2), trimethobenzamide (n = 2), pyrilamine-pentobarbital (n = 2), metoclopramide (n = 2), dexamethasone (n = 1), and promethazine (n = 1). Meta-analysis of 6 randomized, double-masked, placebo-controlled trials of ondansetron demonstrated decreased risk of further vomiting (5 studies; relative risk [RR], 0.45; 95% confidence interval [CI], 0.33-0.62; number needed to treat [NNT] = 5), reduced need for intravenous fluid (4 studies; RR, 0.41; 95% CI, 0.28-0.62; NNT = 5), and decreased risk of immediate hospital admission (5 studies; RR, 0.52; 95% CI, 0.27-0.95; NNT = 14). Diarrheal episodes increased in ondansetron-treated patients in 3 studies. Ondansetron use did not significantly affect return to care (5 studies; RR, 1.34; 95% CI, 0.77-2.35).

Conclusions  Ondansetron therapy decreases the risk of persistent vomiting, the use of intravenous fluid, and hospital admissions in children with vomiting due to gastroenteritis. Future treatment guidelines should incorporate ondansetron therapy for select children with gastroenteritis.

Author Affiliations: Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine (Drs DeCamp, Byerley, and Steiner). Ms Doshi is a medical student at the University of North Carolina at Chapel Hill School of Medicine.

RELATED ARTICLES

This Month in Archives of Pediatrics & Adolescent Medicine
Arch Pediatr Adolesc Med. 2008;162(9):811.
FULL TEXT  

The Effects of Antiemetics for Children With Vomiting Due to Acute, Moderate Gastroenteritis
Rachel C. Vreeman, S. Maria E. Finnell, Erin R. Cernkovich, and Aaron E. Carroll
Arch Pediatr Adolesc Med. 2008;162(9):866-869.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ondansetron Is Useful for Acute Pediatric Gastroenteritis
JWatch Emergency Med. 2008;2008:3-3.
FULL TEXT  

Use of Ondansetron in Children with Gastroenteritis
JWatch Pediatrics 2008;2008:3-3.
FULL TEXT  

The Effects of Antiemetics for Children With Vomiting Due to Acute, Moderate Gastroenteritis
Vreeman et al.
Arch Pediatr Adolesc Med 2008;162:866-869.
FULL TEXT